<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03549611</url>
  </required_header>
  <id_info>
    <org_study_id>201805826</org_study_id>
    <nct_id>NCT03549611</nct_id>
  </id_info>
  <brief_title>Pre-induction Analgesia: Multimodel Regimen vs Aceteminophen for Post Ureteroscopy Pain</brief_title>
  <acronym>MMPITR</acronym>
  <official_title>Randomized Comparison of Two Pre-induction Analgesia Regimens: Multimodal vs Acetaminophen in the Reduction of Post-operative Pain Following Ureteroscopy With Lithotripsy for Kidney Stones Evaluated With Text Messaging</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Kevin J Flynn MD</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University of Iowa</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>Yes</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
    <is_us_export>Yes</is_us_export>
  </oversight_info>
  <brief_summary>
    <textblock>
      Adult patients with kidney stones undergoing surgical intervention with ureteroscopy with&#xD;
      laser lithotripsy will be randomized to receive one of two different regimens of oral&#xD;
      medications administered prior to induction of general anesthesia. Postoperatively, patients&#xD;
      will receive automated daily text messages to assess pain and opioid consumption and&#xD;
      subsequently determine which which treatment regimen is superior.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Adult patients undergoing ureteroscopy for kidney stones will be screened and those who meet&#xD;
      initial study criteria (adult, English speaking, non-pregnant, non-intellectually disabled&#xD;
      patients), will be sent an information letter outlining the study. Interested patients, who&#xD;
      possess a phone capable of text messaging will be consented to enroll in the study and&#xD;
      randomized to one of two preoperative analgesic treatment arms (see below) that will be&#xD;
      administered in the preoperative area prior to induction of general anesthesia.&#xD;
&#xD;
      Multimodal Analgesia Arm&#xD;
&#xD;
        1. Acetaminophen 975mg&#xD;
&#xD;
        2. Gabapentin 800mg&#xD;
&#xD;
        3. Oxycodone 10mg&#xD;
&#xD;
        4. Celecoxib 400mg&#xD;
&#xD;
      Acetaminophen Only Analgesia Arm&#xD;
&#xD;
      a. Acetaminophen 975mg&#xD;
&#xD;
      Consenting patients will fill out a baseline demographics questionnaire as well as provide&#xD;
      baseline levels of pain and opioid consumption prior to surgery. They will also be enrolled&#xD;
      to receive automated postoperative pain assessments and opioid consumption inquiries via text&#xD;
      message. The patients will be blinded to the treatment they are receiving. The research team&#xD;
      will not be blinded. The patient will then proceed with their planned ureteroscopy. The&#xD;
      patient will then undergo their planned ureteroscopy with lithotripsy for kidney stone&#xD;
      disease; the study does not change any parameters about the surgery itself. The general&#xD;
      anesthesia regimen will be standardized to one particular standard of care method so as to&#xD;
      minimize the potential effect of confounders.&#xD;
&#xD;
      All patients (patients in both preoperative analgesia treatment regimen arms) will be&#xD;
      monitored in the post-anesthesia recovery unit for pain, blood pressure, sedation level&#xD;
      monitored by the Ramsey Sedation Scale. Once they have recovered appropriately and met&#xD;
      standard discharge criteria they will be discharged with the following analgesic regimen&#xD;
&#xD;
        1. Tylenol 650 every 6 hours x 7 day&#xD;
&#xD;
        2. Oxybutynin 5mg three times daily as needed for x 7 days&#xD;
&#xD;
        3. Flomax 0.4mg daily x 7 days&#xD;
&#xD;
        4. Oxycodone, 5mg as needed 15 pills&#xD;
&#xD;
        5. Celecoxib daily for 7 days&#xD;
&#xD;
      Patients will receive a pain assessment via text message the evening of postoperative day 0,&#xD;
      and then twice a day for 14 days. Patients will also receive an opioid consumption inquiry&#xD;
      once a day for 14 days. On postoperative day 15 patients will be asked if they were happy&#xD;
      with their postoperative pain control.&#xD;
&#xD;
      During the study period the research team will access the patients electronic medical record&#xD;
      to review and record the following information&#xD;
&#xD;
        -  Current medications&#xD;
&#xD;
        -  height, weight, age, gender, marital status, city, state of residence&#xD;
&#xD;
        -  Co-morbid medical conditions&#xD;
&#xD;
        -  insurance&#xD;
&#xD;
        -  stone parameters: size (mmm), location, laterality, number of stones,&#xD;
&#xD;
        -  Operative factors: instruments used, operative time, operative complications&#xD;
&#xD;
        -  post-operative course: emergency department visits, unexpected phone calls, unexpected&#xD;
           clinic visits, other 30-day complications&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Withdrawn</overall_status>
  <why_stopped>
    elected not to proceed with the study&#xD;
  </why_stopped>
  <start_date type="Anticipated">August 1, 2018</start_date>
  <completion_date type="Anticipated">June 30, 2019</completion_date>
  <primary_completion_date type="Anticipated">June 30, 2019</primary_completion_date>
  <phase>Phase 4</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Single (Participant)</masking>
    <masking_description>The patient will not be made aware which treatment regimen they are receiving and neither will the attending urologist.</masking_description>
  </study_design_info>
  <primary_outcome>
    <measure>Postoperative day 0 Pain</measure>
    <time_frame>4-6 hours after conclusion of surgery</time_frame>
    <description>The magnitude of pain (0-10) that the patient experiences in the evening after their surgery concludes</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Time to pain resolution</measure>
    <time_frame>Approximately the first 72-96 hours</time_frame>
    <description>The amount of time (days) that it takes for patients to report a pain level of less than 4 (0-10 scale)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Opioid Consumption</measure>
    <time_frame>14 days following surgery</time_frame>
    <description>The number of total opioid pills a patient consumes following surgery</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Time to complete pain resolution</measure>
    <time_frame>14 days</time_frame>
    <description>The amount of time (days) that it takes for patients to report a pain level of 0 (0-10 scale)</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">0</enrollment>
  <condition>Kidney Calculi</condition>
  <condition>Pain, Postoperative</condition>
  <arm_group>
    <arm_group_label>Multimodel Drug Regimen</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>The patients randomized to this arm will receive the following multimodal oral drug regimen administered shortly before induction of general anesthesia&#xD;
Tylenol, 975mg (3 tabs)&#xD;
800mg Gabapentin&#xD;
400mg Celecoxib&#xD;
10mg Oxycodone</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Acetaminophen Only</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>The patients randomized to this arm will receive oral acetaminophen only administered shortly before induction of general anesthesia&#xD;
1. Tylenol, 975mg (3 tabs)</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Multimodal Oral Drug Regimen</intervention_name>
    <description>Regimen of 4 pharmacologic agents that provides analgesia by acting on 4 different physiologic pain pathways</description>
    <arm_group_label>Multimodel Drug Regimen</arm_group_label>
    <other_name>Gabapentin 800mg</other_name>
    <other_name>Oxycodone 10mg</other_name>
    <other_name>Acetaminophen 975mg</other_name>
    <other_name>Celecoxib 400mg</other_name>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Acetaminophen</intervention_name>
    <description>Acetaminophen 975mg</description>
    <arm_group_label>Acetaminophen Only</arm_group_label>
    <other_name>Tylenol</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Adult Patient (greater than 18 years old)&#xD;
&#xD;
          -  Possesses or has access to cell phone with text message capability&#xD;
&#xD;
          -  Undergoing ureteroscopy with lithotripsy for a ureteral or kidney stones&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Does not possess or have access to a cell phone with text message capability&#xD;
&#xD;
          -  Non-English speaking&#xD;
&#xD;
          -  Incarcerated individuals&#xD;
&#xD;
          -  undergoing planned secondary procedure&#xD;
&#xD;
          -  pregnancy&#xD;
&#xD;
          -  intellectual disability&#xD;
&#xD;
          -  History of, anaphylactic, rash, or other hypersensitivity reaction to any of the study&#xD;
             agents&#xD;
&#xD;
          -  Patients with history of CABG, myocardial infarction, endovascular cardiac stent,&#xD;
             gastrointestinal bleed, or gastric ulcer disease will not receive Celecoxib. They may&#xD;
             still participate in the study otherwise, it will be documented that they did not&#xD;
             receive an NSAID component.&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>100 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Chad Tracy, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>University of Iowa Department of Urology</affiliation>
  </overall_official>
  <reference>
    <citation>Ahn ST, Kim JH, Park JY, Moon du G, Bae JH. Acute postoperative pain after ureteroscopic removal of stone: incidence and risk factors. Korean J Urol. 2012 Jan;53(1):34-9. doi: 10.4111/kju.2012.53.1.34. Epub 2012 Jan 25.</citation>
    <PMID>22323972</PMID>
  </reference>
  <reference>
    <citation>Penprase B, Brunetto E, Dahmani E, Forthoffer JJ, Kapoor S. The efficacy of preemptive analgesia for postoperative pain control: a systematic review of the literature. AORN J. 2015 Jan;101(1):94-105.e8. doi: 10.1016/j.aorn.2014.01.030. Review.</citation>
    <PMID>25537330</PMID>
  </reference>
  <reference>
    <citation>Scales CD Jr, Smith AC, Hanley JM, Saigal CS; Urologic Diseases in America Project. Prevalence of kidney stones in the United States. Eur Urol. 2012 Jul;62(1):160-5. doi: 10.1016/j.eururo.2012.03.052. Epub 2012 Mar 31.</citation>
    <PMID>22498635</PMID>
  </reference>
  <reference>
    <citation>Oberlin DT, Flum AS, Bachrach L, Matulewicz RS, Flury SC. Contemporary surgical trends in the management of upper tract calculi. J Urol. 2015 Mar;193(3):880-4. doi: 10.1016/j.juro.2014.09.006. Epub 2014 Sep 16.</citation>
    <PMID>25219700</PMID>
  </reference>
  <reference>
    <citation>Barnes KT, Bing MT, Tracy CR. Do ureteric stent extraction strings affect stent-related quality of life or complications after ureteroscopy for urolithiasis: a prospective randomised control trial. BJU Int. 2014 Apr;113(4):605-9. doi: 10.1111/bju.12541.</citation>
    <PMID>24765679</PMID>
  </reference>
  <reference>
    <citation>Hirschtritt ME, Delucchi KL, Olfson M. Outpatient, combined use of opioid and benzodiazepine medications in the United States, 1993-2014. Prev Med Rep. 2017 Dec 21;9:49-54. doi: 10.1016/j.pmedr.2017.12.010. eCollection 2018 Mar.</citation>
    <PMID>29340270</PMID>
  </reference>
  <verification_date>December 2018</verification_date>
  <study_first_submitted>May 25, 2018</study_first_submitted>
  <study_first_submitted_qc>May 25, 2018</study_first_submitted_qc>
  <study_first_posted type="Actual">June 8, 2018</study_first_posted>
  <last_update_submitted>December 21, 2018</last_update_submitted>
  <last_update_submitted_qc>December 21, 2018</last_update_submitted_qc>
  <last_update_posted type="Actual">December 26, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor-Investigator</responsible_party_type>
    <investigator_affiliation>University of Iowa</investigator_affiliation>
    <investigator_full_name>Kevin J Flynn MD</investigator_full_name>
    <investigator_title>Urology Resident</investigator_title>
  </responsible_party>
  <keyword>ureteroscopy</keyword>
  <keyword>opioids</keyword>
  <keyword>narcotics</keyword>
  <keyword>text messaging</keyword>
  <keyword>real time data acquisition</keyword>
  <keyword>ecologic momentary assessments</keyword>
  <keyword>pre-emptive analgesia</keyword>
  <keyword>gabapentin</keyword>
  <keyword>meloxicam</keyword>
  <keyword>tamsulosin</keyword>
  <keyword>kidney stones</keyword>
  <keyword>lithotripsy</keyword>
  <keyword>nephrolithiasis</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Kidney Calculi</mesh_term>
    <mesh_term>Nephrolithiasis</mesh_term>
    <mesh_term>Pain, Postoperative</mesh_term>
    <mesh_term>Calculi</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Acetaminophen</mesh_term>
    <mesh_term>Celecoxib</mesh_term>
    <mesh_term>Oxycodone</mesh_term>
    <mesh_term>Gabapentin</mesh_term>
  </intervention_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
    <ipd_description>Data will not be shared</ipd_description>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

